Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 122,600 shares, a growth of 63.7% from the February 13th total of 74,900 shares. Based on an average daily volume of 395,100 shares, the short-interest ratio is presently 0.3 days. Approximately 6.1% of the company’s stock are short sold.
Aptose Biosciences Stock Down 2.4 %
Aptose Biosciences stock opened at $3.69 on Friday. Aptose Biosciences has a twelve month low of $2.39 and a twelve month high of $51.61. The stock’s 50 day moving average is $5.13 and its 200 day moving average is $8.10. The company has a market capitalization of $7.90 million, a P/E ratio of -1.24 and a beta of 1.14.
Institutional Trading of Aptose Biosciences
An institutional investor recently raised its position in Aptose Biosciences stock. Sigma Planning Corp boosted its holdings in shares of Aptose Biosciences Inc. (NASDAQ:APTO – Free Report) (TSE:APS) by 71.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 401,750 shares of the biotechnology company’s stock after buying an additional 167,282 shares during the quarter. Sigma Planning Corp owned approximately 2.22% of Aptose Biosciences worth $165,000 at the end of the most recent quarter. 26.62% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on APTO
Aptose Biosciences Company Profile
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
See Also
- Five stocks we like better than Aptose Biosciences
- Basic Materials Stocks Investing
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Investing in the High PE Growth Stocks
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Top Stocks Investing in 5G Technology
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.